Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe Robins

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nature Medicine|July 22, 2024
Proteomic signatures improve risk prediction for common and rare diseasesJulia Carrasco-Zanini, Maik Pietzner, Jonathan Davitte, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 5, 2026
APOE-stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's DiseaseFuhai Li, Yike Chen, Daniel Western, et al.
Research Square|February 27, 2024
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's diseaseCarlos Cruchaga, Muhammad Ali, Yuanyuan Shen, et al.
Neuron|March 15, 2025
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumMuhammad Ali, Jigyasha Timsina, Daniel Western, et al.
Nature|October 4, 2023
Plasma proteomic associations with genetics and health in the UK BiobankBenjamin B Sun, Joshua Chiou, Matthew Traylor, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature Medicine|July 22, 2024
Proteomic signatures improve risk prediction for common and rare diseasesJulia Carrasco-Zanini, Maik Pietzner, Jonathan Davitte, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 5, 2026
APOE-stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's DiseaseFuhai Li, Yike Chen, Daniel Western, et al.
Research Square|February 27, 2024
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's diseaseCarlos Cruchaga, Muhammad Ali, Yuanyuan Shen, et al.
Neuron|March 15, 2025
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumMuhammad Ali, Jigyasha Timsina, Daniel Western, et al.
Nature|October 4, 2023
Plasma proteomic associations with genetics and health in the UK BiobankBenjamin B Sun, Joshua Chiou, Matthew Traylor, et al.
Pageof 2